Thyroid problems are very common, and millions of people take medication every day to manage them. One of the most widely prescribed medicines for thyroid disease is levothyroxine. In the United ...

A study tracking women for more than two decades adds to growing evidence that when menopause hormone therapy is started may influence dementia risk later in life.

Researchers led by a scientist at UC San Diego examined blood samples collected in the 1990s to detect a key biomarker’s ...

WV lawmakers, on March 11, 2026 push their plan for the state to pay for hormone therapy in an effort to reverse effects of ...

After recent years of being the focus of an aggressive legislative push to mitigate their access to health care, transgender prisoners now face a similar offensive. President Donald Trump has instated ...

Women who previously had endometrial cancer and used vaginal estrogen therapy did not have higher risk for cancer recurrence than those who did not use vaginal hormone therapy, according to findings ...

Women with higher levels of p-tau217, a blood protein, were twice as likely to eventually develop dementia or mild cognitive impairment.

Roughly 1 in 8 US women are expected to be diagnosed with invasive breast cancer at some point. It’s the most common cancer in women, excluding skin cancers.

Ivim Health reports that peptide therapies, spurred by GLP-1 interest, require careful understanding and medical oversight for safe use.

After one of El Paso’s only pediatric endocrinologists was accused of illegally providing gender-transitioning treatments to kids, his patients who aren’t transgender lost care.

With the removal of FDA warning labels, hormone therapy to treat symptoms of menopause has grown in popularity. Now some ...

With the removal of the black-box warning on hormone therapy for menopause, some providers and patients report shortages or delays, waiting for a pharmacy to restock transdermal estrogen patches.